MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer

Ovarian cancer is the most lethal gynecologic malignancy. Recently, several molecularly targeted anticancer agents have been developed for ovarian cancer; however, its prognosis remains extremely poor. The development of molecularly targeted therapy, as well as companion diagnostics, is required to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukagawa, Satoshi, Miyata, Kohei, Yotsumoto, Fusanori, Kiyoshima, Chihiro, Nam, Sung Ouk, Anan, Haruchika, Katsuda, Takahiro, Miyahara, Daisuke, Murata, Masaharu, Yagi, Hiroshi, Shirota, Kyoko, Yasunaga, Shin'ichiro, Kato, Kiyoko, Miyamoto, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448652/
https://www.ncbi.nlm.nih.gov/pubmed/28231414
http://dx.doi.org/10.1111/cas.13210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448652/
https://www.ncbi.nlm.nih.gov/pubmed/28231414
http://dx.doi.org/10.1111/cas.13210

Ejemplares similares